K090081 is an FDA 510(k) clearance for the TALLADIUM INTERNATIONAL IMPLANTOLOGY ABUTMENTS. Classified as Abutment, Implant, Dental, Endosseous within the NHA classification (a category for dental implant abutments and prosthetic components), Class II - Special Controls.
Submitted by Talladium Espana, SL (Lleida, ES). The FDA issued a Cleared decision on June 22, 2010 after a review of 526 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3630 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Dental submissions.
View all Talladium Espana, SL devices